This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Dec;102(12):509-12.

doi: 10.1258/jrsm.2009.090293.

The polypill story from a ringside seat

Richard Smith¹

Affiliations

PMID: 19966125
PMCID: PMC2789023
DOI: 10.1258/jrsm.2009.090293

The polypill story from a ringside seat

Richard Smith. J R Soc Med. 2009 Dec.

. 2009 Dec;102(12):509-12.

doi: 10.1258/jrsm.2009.090293.

Author

Richard Smith¹

Affiliation

¹ Ovations Chronic Disease Initiative 35 Orlando Road, London SW4 0LD, UK. richardswsmith@yahoo.co.uk

PMID: 19966125
PMCID: PMC2789023
DOI: 10.1258/jrsm.2009.090293

No abstract available

PubMed Disclaimer

Similar articles

[Is the "polypill" in cardiovascular prevention an option].
Flatz A, Renard D, von Elm E. Flatz A, et al. Praxis (Bern 1994). 2015 Mar 11;104(6):305-6. doi: 10.1024/1661-8157/a001935. Praxis (Bern 1994). 2015. PMID: 25758972 German. No abstract available.
The preventive polypill--much promise, insufficient evidence.
Reddy KS. Reddy KS. N Engl J Med. 2007 Jan 18;356(3):212. doi: 10.1056/NEJMp068219. N Engl J Med. 2007. PMID: 17229947 No abstract available.
Could the polypill improve adherence? The patient perspective.
Bryant L, Martini N, Chan J, Chang L, Marmoush A, Robinson B, Yu K, Wong M. Bryant L, et al. J Prim Health Care. 2013 Mar 1;5(1):28-35. J Prim Health Care. 2013. PMID: 23457692
The polypill: a potential global solution to cardiovascular disease.
Nguyen C, Cheng-Lai A. Nguyen C, et al. Cardiol Rev. 2013 Jan-Feb;21(1):49-54. doi: 10.1097/CRD.0b013e3182755429. Cardiol Rev. 2013. PMID: 23018668 Review.
The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention.
Tamargo J, Castellano JM, Fuster V. Tamargo J, et al. Int J Cardiol. 2015 Dec;201 Suppl 1:S15-22. doi: 10.1016/S0167-5273(15)31028-7. Int J Cardiol. 2015. PMID: 26747390 Review.

See all similar articles

Cited by

A 3D-Printed Polymer-Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations.
Barber BW, Dumont C, Caisse P, Simon GP, Boyd BJ. Barber BW, et al. Pharmaceutics. 2021 Dec 7;13(12):2107. doi: 10.3390/pharmaceutics13122107. Pharmaceutics. 2021. PMID: 34959390 Free PMC article.
Adoption and scale-up of the cardiovascular Polypill: a realist institutional analysis.
Abimbola S, Liu H. Abimbola S, et al. Health Policy Plan. 2023 Jan 6;38(1):15-27. doi: 10.1093/heapol/czac088. Health Policy Plan. 2023. PMID: 36271837 Free PMC article.
Redefining the polypill: pros and cons in cardiovascular precision medicine.
Birla S, Angural A, Madathumchalil A, Shende RV, Shastry SV, Mahadevappa M, Shambhu SK, Vishwanath P, Prashant A. Birla S, et al. Front Pharmacol. 2023 Sep 19;14:1268119. doi: 10.3389/fphar.2023.1268119. eCollection 2023. Front Pharmacol. 2023. PMID: 37799963 Free PMC article. Review.

References

1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419–23 - PMC - PubMed
1. Law MR, Wald NJ, Rudnicka A. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003;326:1423–7 - PMC - PubMed
1. Law MR, Wald NJ, Morris JK, Jordan R. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427–31 - PMC - PubMed
1. Yusuf S. Two decades of progress in preventing cardiovascular disease. Lancet 2002;360:2–3 - PubMed
1. Smith R. The most important BMJ for 50 years? BMJ 2003;326: doi:10.1136/bmj.326.7404.o-f

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources